Here are four things to know.
1. Predominately using opioids to manage pain is often associated with multiple adverse effects. The study authors sought to determine if adding 150 milligrams of pregabalin daily would reduce narcotic requirements and improve outcomes after PLF.
2. The randomized, controlled trial involved 86 elective PLF patients who were assigned to receive 150 milligrams of pregabalin one hour before surgery and then 150 milligrams daily after surgery, or a placebo tablet.
3. Demographics and operative time between groups were similar; each group consisted of 43 patients. PCA hydromorphone administration and oral narcotic intake were not statistically different between the two groups. There was no difference in achieving physical therapy milestones and hospital discharge day.
4. The authors were unable to show an analgesic advantage to prescribing pregabalin to patients undergoing lumbar spinal fusion.
More articles on spine:
Spine surgeons perform surgeries live: 4 highlights
Former Swedish Neuroscience Institute Chair Dr. Johnny Delashaw claims conspiracy — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.